The financials
Inspire Medical Systems, Inc. by the numbers
Inspire Medical Systems, Inc. (INSP) reported revenue of $205M in Q1 2026 (quarter ended March 31, 2026), up 1.6% from the same quarter a year earlier. That came with a gross margin of 86% and net loss of $11M. For the full year FY2025, revenue was $912M (+14% year on year) and net income $145M. Its largest region in 2026-Q1 was US at $196M, 96% of the disclosed total, just ahead of Non Us at 4.4%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $205M | $201M | +1.6% |
| Gross profit | $177M | $171M | +3.7% |
| Operating income | −$1.1M | −$1.5M | n/a |
| Net income | −$11M | $3.0M | to a loss |
| Diluted EPS | −$0.39 | $0.10 | to a loss |
| Geographic | Revenue | Share |
|---|---|---|
| US | $196M | 96% |
| Non Us | $9.0M | 4.4% |
Business Segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Q1 2026Total $204.6M (-8.9%)
Non Us grew +16% year on yearUS +1.0% year on year
Segment Latestquarter on quarteryear on year
- US$195.6M$195.6MQoQ -8.8%year on year +1.0%-8.8%+1.0%
- Non Us$9.0M$9.0MQoQ -11%year on year +16%-11%+16%